Medical Condition News RSS Feed - Medical Condition News

Study provides detailed brain map of language impairments in aphasia after stroke

Study provides detailed brain map of language impairments in aphasia after stroke

The exchange of words, speaking and listening in conversation, may seem unremarkable for most people, but communicating with others is a challenge for people who have aphasia, an impairment of language that often happens after stroke or other brain injury. [More]
RegeneRx joint venture retains Ora to carry out RGN-259/GBT201 clinical trials in U.S.

RegeneRx joint venture retains Ora to carry out RGN-259/GBT201 clinical trials in U.S.

RegeneRx Biopharmaceuticals, Inc. today announced its U.S. joint venture with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. to conduct a phase 3 clinical trial for the orphan disorder, neurotrophic keratopathy (NK), and a 2b/3 dose-response, confirmatory trial for dry eye syndrome (DES) in the U.S. Both trials will be testing ReGenTree's preservative-free eye drops, RGN-259/GBT201, this year. [More]
Children who experience multiple traumatic events face risk of being hypertensive adults

Children who experience multiple traumatic events face risk of being hypertensive adults

Children who experience multiple traumatic events, from emotional and sexual abuse to neglect, have higher blood pressures as young adults than their peers, researchers report. [More]
Electronic micropump combined with anticonvulsant drug may treat brain diseases

Electronic micropump combined with anticonvulsant drug may treat brain diseases

Many potentially efficient drugs have been created to treat neurological disorders, but they cannot be used in practice. Typically, for a condition such as epilepsy, it is essential to act at exactly the right time and place in the brain. [More]
Baxter submits BAX 855 NDA to Japan's MHLW for treatment of hemophilia A patients

Baxter submits BAX 855 NDA to Japan's MHLW for treatment of hemophilia A patients

Nektar Therapeutics reported today that partner Baxter International Inc. announced that the company has submitted a new drug application (NDA) to Japan's Ministry of Health, Labour and Welfare for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment based on ADVATE [Antihemophilic Factor (Recombinant)] for patients over 12 years of age with hemophilia A. [More]
Researchers use virtual reality to develop new method for measuring balance control in glaucoma patients

Researchers use virtual reality to develop new method for measuring balance control in glaucoma patients

Falls are the leading cause of injury-related death and morbidity in older adults, especially those with a chronic eye disease such as glaucoma. To investigate this problem, a multidisciplinary group of researchers has become the first to use virtual reality technology to develop a new method for measuring balance control in those with glaucoma. [More]
Wilson Therapeutics' WTX101-201 Phase 2 clinical study to be presented at EASL annual meeting

Wilson Therapeutics' WTX101-201 Phase 2 clinical study to be presented at EASL annual meeting

Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26. [More]
HeartWare Ventricular Assist System meets primary endpoint in ENDURANCE clinical trial

HeartWare Ventricular Assist System meets primary endpoint in ENDURANCE clinical trial

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial achieved the primary endpoint. [More]
Veracyte launches new genomic test to improve lung cancer diagnosis

Veracyte launches new genomic test to improve lung cancer diagnosis

Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin testing patient samples in its CLIA-certified laboratory, with the Percepta test now available to a limited number of institutions around the country. [More]
New research links sleep apnea, heavy snoring with premature cognitive decline

New research links sleep apnea, heavy snoring with premature cognitive decline

Heavy snoring and sleep apnea may be linked to memory and thinking decline at an earlier age, according to a new study published in the April 15, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
GW Cancer Institute finalizes competency statements for oncology patient navigators

GW Cancer Institute finalizes competency statements for oncology patient navigators

The George Washington University Cancer Institute has finalized 45 core competency statements for oncology patient navigators, who have become critical members of the health care team. These competency statements were published in the Journal of Oncology Navigation and Survivorship and were created through literature review, focus group data analysis, expert review, and a national survey of oncology patient navigation stakeholders. [More]
Yale University launches clinical study to evaluate personalized medicine for metastatic melanoma

Yale University launches clinical study to evaluate personalized medicine for metastatic melanoma

Yale University has launched a multicenter clinical trial, sponsored by Stand Up to Cancer and Melanoma Research Alliance, that will apply the latest in personalized medicine technology to treat metastatic melanoma. The trial, for which Yale is a lead site, will enroll patients lacking a particular genetic mutation for whom immune therapy did not work or was not an option. [More]
Two UC Davis researchers awarded grant to help improve surveillance for patients with small lung nodules

Two UC Davis researchers awarded grant to help improve surveillance for patients with small lung nodules

Two UC Davis researchers will help run a major national study to improve surveillance practices for patients with small lung nodules identified on CT imaging and extremely low risk for lung cancer. [More]
Racial and ethnic minority groups face disproportionate rates of smoking, health-related illnesses

Racial and ethnic minority groups face disproportionate rates of smoking, health-related illnesses

April is National Minority Health Month, and one of the most significant health issues minorities face is disproportionate rates of smoking and health-related illnesses. [More]
Study looks at dabigatran adherence across Veterans Health Administration sites

Study looks at dabigatran adherence across Veterans Health Administration sites

Among patients with atrial fibrillation who filled prescriptions for the anticoagulant dabigatran at Veterans Health Administration sites, there was variability in patient medication adherence across sites, with appropriate patient selection and pharmacist-led monitoring associated with greater adherence to the medication, according to a study in the April 14 issue of JAMA. [More]

Study examines outcomes following mechanical prosthetic vs bioprosthetic mitral valve replacement

In a comparison of mechanical prosthetic vs bioprosthetic mitral valves among patients 50 to 69 years of age undergoing mitral valve replacement, there was no significant difference in survival at 15 years, although there were differences in risk of reoperation, bleeding and stroke, according to a study in the April 14 issue of JAMA. [More]
Research: Stem cell injection may soon slow or reverse effects of age-related macular degeneration

Research: Stem cell injection may soon slow or reverse effects of age-related macular degeneration

An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai. Currently, there is no treatment that slows the progression of the disease, which is the leading cause of vision loss in people over 65. [More]
High-fat diet can alter your muscle metabolism, new study finds

High-fat diet can alter your muscle metabolism, new study finds

You might think that you can get away with eating fatty foods for a few days without it making any significant changes to your body. Think again. After just five days of eating a high-fat diet, the way in which the body's muscle processes nutrients changes, which could lead to long-term problems such as weight gain, obesity, and other health issues, a new study has found. [More]
UW researchers use Activa PC+S DBS system to treat essential tremor

UW researchers use Activa PC+S DBS system to treat essential tremor

Essential tremor, a nervous system disorder that causes a rhythmic shaking in the hands, affects an estimated 10 million Americans and millions more worldwide. Deep brain stimulation, essentially a pacemaker for the brain, has been approved to treat essential tremor. But there is not an existing system that automatically provides electrical stimulation only when needed. [More]
New study shows nicotine exposure promotes alcohol dependence

New study shows nicotine exposure promotes alcohol dependence

Why do smokers have a five to ten times greater risk of developing alcohol dependence than nonsmokers? Do smokers have a greater tendency toward addiction in general or does nicotine somehow reinforce alcohol consumption? Now, a study led by scientists at The Scripps Research Institute helps provide insight into these questions, showing that, in rat models, nicotine exposure actually promotes alcohol dependence. [More]
Advertisement
Advertisement